DJIA 17,826.30 -279.47 -1.54%
NASDAQ 4,931.82 -75.98 -1.52%
S&P 500 2,081.18 -23.81 -1.13%
market minute promo

Exelixis (NASDAQ: EXEL)

3.11 0.01 (0.32%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

EXEL $3.11 0.32%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.10
Previous Close $3.10
Daily Range $3.03 - $3.14
52-Week Range $1.26 - $4.55
Market Cap $609.2M
P/E Ratio -2.25
Dividend (Yield) $0.00 (0.0%)
Volume 1,719,492
Average Daily Volume 3,074,621
Current FY EPS -$0.86




Drug Makers

Exelixis (EXEL) Description

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. Website:

News & Commentary

3 Biotech Stocks That May Disappear Before 2020

Our experts weigh in.

3 Momentum Picks Under $10 to Sail the Turbulent Market - Analyst Blog

Exelexis (EXEL) Is The 'Chart of the Day'

2 Speculative Biotechs That Could Be Well Worth the Risk

Celladon Corp. and Exelixis Inc. are two speculative biotech stocks that might be worth their substantial risks.

Exelixis' Cometriq Gets Fast Track Status in U.S. - Analyst Blog

Exelixis (EXEL) Stock Rises Today Following FDA Fast Track Designation

Health Care Sector Update for 04/09/2015: EXEL,NVGN,TRIV

Morning Market Gainers

Biotech Weekly: Why Financials Matter

5 Promising Biotech Stocks Under $10

Don't let their share price fool you. These five biotech stocks have the potential to double your money many times over if their product pipelines meet expectations.

See More EXEL News...

EXEL's Top Competitors

EXEL $3.11 (0.32%)
Current stock: EXEL
TMO $132.10 (-0.29%)
Current stock: TMO
ILMN $191.16 (-0.96%)
Current stock: ILMN
WAT $124.41 (-0.42%)
Current stock: WAT